SCHEMBL5654622

SCHEMBL5654622

CCCn1ccnc1-c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.45
TLR8 Q9NR97 3/20 0.44
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
ADORA2B P29275 4/20 0.42
KEAP1 Q14145 1/20 0.40
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
ALOX15 P16050 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1885040 0.86 ESR1 (0.47) ESR1TLR8ALDH1A1POLBKMT2A
SCHEMBL3151691 0.86 ALDH1A1 (0.43) ESR1TLR8ALDH1A1POLBKMT2A
SCHEMBL9444420 0.83 ESR1 (0.64) ESR1ALDH1A1POLBKMT2AADORA2B
SCHEMBL4487882 0.83 ESR1 (0.42) ESR1TLR8ALDH1A1ADORA2BKEAP1
SCHEMBL17743804 0.78 ESR1 (0.51) ESR1NPC1RAB9ACYP3A4CYP2C9
SCHEMBL77337 0.77 HDAC4 (0.47) ALDH1A1KMT2AKEAP1KDM4EHPGD
SCHEMBL27831726 0.77 KMT2A (0.59) ESR1TLR8ALDH1A1POLBKMT2A
SCHEMBL13943558 0.76 ESR1 (0.47) ESR1ALDH1A1POLBKMT2AADORA2B
SCHEMBL27327494 0.75 BRD4 (0.40) ESR1TLR8ALDH1A1POLBKMT2A
SCHEMBL15769685 0.74 ALDH1A1 (0.50) ESR1TLR8ALDH1A1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262185-B2 Benzazepine derivative, process for producing the same, and use TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2007-08-28 US disclosed
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use CYP1B1, CYP1A1, CYP2E1 ESR1 987/4885TLR8 4213/4885ALDH1A1 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.